entertainment -WSS

entertainment

author：entertainment 2025-09-29 14:00:22 - browse：758

Sarepta - Cambridge -AP — A logo sign outside of the headquarters of Sarepta Therapeutics in Cambridge, Mass. Kristoffer Tripplaar/Sipa via AP

Reviewers at the Food and Drug Administration were leaning toward rejecting a closely watched gene therapy for Duchenne muscular dystrophy made by Sarepta Therapeutics, prompting a top official to intervene earlier this year, according to three people with direct knowledge of the agency deliberations.

Inside the FDA office that oversees gene therapies, some staff had reached a non-binding conclusion that Sarepta’s gene therapy should be rejected, the individuals said, speaking on condition of anonymity. Peter Marks, a top FDA official and vocal advocate for faster gene therapy approvals, stepped in and directed staff to schedule a public hearing on the therapy on May 12.

Sarepta announced the scheduling of the public hearing last month, but the internal deliberations that led to it have not been previously reported.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Eli Lilly buys Point Biopharma in radiopharmaceuticals play

knowledge

focus

WSS

A virus, fished out of a lake, may have saved a man’s life

Why Charlie Gard's case is so disturbing to Americans

New menopause drug shows promise in relief for hot flashes

Phenylephrine and the overlooked value of the placebo effect

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Biotech reporter’s notebook: A sunnier mood at JPM 2024

leisure time

entertainment

focus

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

3 questions for the future of Biden's cancer moonshot

Affirmative action in medical school literally saved lives

GSK to buy asthma

Tori Bowie and the unacceptable rates of Black maternal death

Doulas covered by Medicaid under New York's new plan

Hollywood unions extend contract negotiations for actors

When women are denied an abortion, their children fare worse than peers

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

explore

Colorectal cancer study finds potential in overlooked immune cell

Heart disease and mental health: A look at cardiac psychology

The future of health care in the House

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

A virus, fished out of a lake, may have saved a man’s life

Stroke deaths set to near 10 million globally by 2050

knowledge

leisure time

focus

hotspot